The Heart Valve Devices Market is valued at USD 12.18 Billion in 2024 and is expected to reach USD 41.88 Billion by 2035 at a ...

“This is the largest series of high-risk patients with symptomatic aortic regurgitation that have been treated with the JenaValve,” Makkar said at the press conference. “The 30-day all-cause ...